Mitochondrial complex-1 in Parkinson's disease

Neurology India

Volumn 54, Issue 4, 2006, Pages 351-

  Khan, Shoeb Zafar ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE;

CLINICAL FEATURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; NOTE; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PROGNOSIS; RIGIDITY; SUBSTANTIA NIGRA; TREMOR; WILD TYPE;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ELECTRON TRANSPORT COMPLEX I; HUMANS; LYMPHOCYTES; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY;

EID: 33845316736     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Shinde S, Pasupathy K. Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from patients with Parkinson's disease: Preliminary study. Neurol India 2006;54:390-3.
2. Abou-Sleiman PM, Muqit MM, Wood NW. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat Rev Neurosci 2006;7:207-19.
3. Dorsey ER, Holloway RG, Ravina BM. Biomarkers in Parkinson's disease. Expert Rev Neurother 2006;6:823-31.
4. Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AH, Marsden CD. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 1992;115:333-42.
5. Kikuchi A, Takeda A, Onodera H, Kimpara T, Hisanaga K, Sato N, et al. Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiol Dis 2002;9:244-8.